Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Thessaly
About this trial
This study assesses whether patients with pancreatic cancer who undergo surgery experience improved outcomes following the implementation of a multidisciplinary care pathway, specifically an enhanced recovery after surgery (ERAS) program.
This pathway includes various interventions in the preoperative, intraoperative, and postoperative care of these patients, all aimed at enhancing their health status and postoperative results.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adult patients
diagnosis of pancreatic cancer
elective open pancreatic surgery
Disqualifiers
age <18 years
emergency pancreatic surgery
other surgical procedures
missing data
Trial population
Patients undergoing pancreatic surgery in two pancreatic cancer referral centers in central Greece, namely the University Hospital of Larissa, and IASO Thessalias general hospital
Trial design
Design model
Case-control
Time perspective
Other
Treatments tested in this trial
enhanced recovery after surgery
Other interventionERAS group follows the enhanced recovery after surgery program which involves 20 elements
Treatment groups
170 Participants
are divided into 2 treatment groupsGroup A: Control group0 interventions
Group B: ERAS group1 intervention
Trial outcomes
Primary outcomes
1
impact on length of stay
total number of days spent in the hospital including any readmission
Time frame
within 30 days of surgerySecondary outcomes
1
impact on overall morbidity
number of any perioperative adverse events
Time frame
within 30 days from surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov